Aurobindo units recall products in US market for manufacturing issues

The affected lot of the medication, which is used to treat high blood pressure, has been manufactured in India and marketed in the US market by Aurobindo Pharma USA, Inc. As per the USFDA, the company is recalling the affected lot due to "Current good manufacturing practices CGMP deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vExsjdG
via IFTTT